Marina Aloi
Marina Aloi is an expert in Gastroenterology at Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (Italy). As of October 2026, ScienceLeadR ranks Marina Aloi in the top 1% of experts worldwide for Crohn Disease, Colitis and Inflammatory Bowel Diseases. Marina Aloi has authored 337 publications, the most recent in 2026, and is an investigator in 17 clinical trials, 6 of them ongoing. SLR score: 1,132 (community average: 125). How the SLR is computed.
LeadR Profile
Gastroenterology
Subspecialties: Pediatrics - Nutrition - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2006 - 2026
Number : 337
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Vulvar Crohn's disease in children: Diagnostic challenges and therapeutic implications from a literature review. PMID 42929334 — crohn disease, biopsy, intestinal diseases, diagnosis, therapeutics, gastrointestinal diseases, child, vulvar diseases | J Pediatr Gastroenterol Nutr | 2026 | 0 |
| Current practices and unmet needs in the management of Clostridioides difficile infection in pediatric inflammatory bowel disease: A national survey. PMID 42755036 — research design, clostridioides, fidaxomicin, vancomycin, clostridioides difficile, inflammatory bowel diseases, diagnosis, therapeutics, gastrointestinal diseases, colitis, ulcerative, infections, child | J Pediatr Gastroenterol Nutr | 2026 | 0 |
| Corrigendum to "Innovation and sustainability in immune-mediated diseases: An Italian multidisciplinary consensus across gastroenterology, dermatology, and rheumatology" [Digestive and Liver Disease 58 (2026) 1051-1060]. PMID 42669572 — liver diseases, rheumatology, gastroenterology, liver, dermatology | Dig Liver Dis | 2026 | 0 |
| Management of pediatric Crohn's disease: an ECCO-ESPGHAN guideline update. PMID 42618885 — crohn disease, pharmaceutical preparations, drug monitoring, inflammatory bowel diseases, therapeutics, enteral nutrition | J Crohns Colitis | 2026 | 1 |
| Comparative effectiveness of adalimumab versus infliximab in children with Crohn's disease: real-world data from the prospective PIBD-SETQuality inception cohort study. PMID 42549261 — crohn disease, cohort studies, inflammatory bowel diseases, adalimumab, therapeutics, steroids, child, infliximab | Crohns Colitis 360 | 2026 | 0 |
Clinical Studies 17
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Ongoing Clinical Trials
6 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| A study to test how well PLENVU a bowel cleansing medicine works in children and teenagers before they have a colonoscopy exam 2025-522046-42-00 — safety, colonic diseases, colonoscopy, child | Phase 3 | Recruiting | 2026 |
| A Study of how the Medicine Called Etrasimod Works in Children With the gut Disease Called Ulcerative Colitis 2025-523100-77-00 — colitis, safety, colitis, ulcerative, child, pharmacokinetics | Phase 2 | Recruiting | 2026 |
| A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis NCT06865417 — colitis, safety, tablets, maintenance, food, aged, therapeutics, colitis, ulcerative, child, pharmacokinetics | Phase 3 | Recruiting | 2025 |
| Study on Eating Habits and Association with omic Profiles in Families with a Subject Affected by a Chronic Immune mediated Inflammatory Pathology Observational Multicenter Study NCT06862843 — colitis, blood, eating, crohn disease, arthritis, pathology, feeding behavior, diet records, diet, mediterranean, diet, food, arthritis, juvenile, gastrointestinal microbiome, colitis, ulcerative, microbiota, joints | N/A | Recruiting | 2024 |
| A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn s Disease (CD) NCT05442567 — colitis, safety, crohn disease, pharmaceutical preparations, drug therapy, therapeutics, colitis, ulcerative, child | Phase 3 | Recruiting | 2023 |
LeadR Networks
Main global connection map